Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
| IHI | UGH-SSF | |
|---|---|---|
| Held by both | ||
 Intuitive Surgical Inc | 14.92% | 2.89% |
 Edwards Lifesciences | 4.52% | 2.37% |
| Only in IHI | ||
 Abbott Laboratories | 17.77% | N/A |
 Medtronic PLC | 11.47% | N/A |
 IDEXX Laboratories Inc | 4.58% | N/A |
 DexCom | 4.55% | N/A |
| Only in UGH-SSF | ||
 Eli Lilly and Co | N/A | 9.20% |
 Merck & | N/A | 5.45% |
 Johnson & Johnson | N/A | 4.98% |
 Unitedhealth Group | N/A | 4.36% |
30 Dec 2025 → 2 Nov 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| UGH-SSF | +7.27% | 15.38% | 0.47 |
| IHI | −8.72% | 21.99% | −0.40 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | IHI | UGH-SSF |
|---|---|---|
Fund details | ||
| Fund size | N/A | 41.09 million |
| Inception date | N/A | 9 Sep 2014 |
| Master fund | N/A | กองทุน United Global Healthcare Fund |
| Dividend policy | N/A | Does not pay |
Risk and currency hedging | ||
| Risk level | N/A | 7 |
| Hedging policy | N/A | Hedged at the manager's discretion |
| Share hedged | N/A | 96.38% |
Minimum purchase and redemption | ||
| First purchase | N/A | 0.01 THB |
| Subsequent purchase | N/A | 0.01 THB |
| Redemption (amount) | N/A | 0.01 THB |
| Redemption (units) | N/A | No minimum |
| Balance (amount) | N/A | No minimum |
| Balance (units) | N/A | No minimum |
Order cut-off and redemption payment | ||
| Buy before | N/A | 15:30 |
| Redeem before | N/A | 14:00 |
| Redemption paid | N/A | T+5 |
